Sponsor

Alzheimer's Disease Cooperative Study (ADCS)

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Alzheimer's Disease Cooperative Study (ADCS) appears in 22 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials22
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

22 shown
"Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program"NCT05350410 · lead sponsor · 2022-04-05
COMPLETED
Prazosin for Agitation in Alzheimer's DiseaseNCT03710642 · lead sponsor · 2018-10-23
COMPLETED
Resveratrol for Alzheimer's DiseaseNCT01504854 · lead sponsor · 2012-05-01
COMPLETED
Alzheimer's Disease Neuroimaging Initiative Grand OpportunityNCT01078636 · lead sponsor · 2010-04-01
COMPLETED
Home-Based Assessment for Alzheimer Disease PreventionNCT00546767 · lead sponsor · 2007-09-01
COMPLETED
DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's DiseaseNCT00440050 · lead sponsor · 2007-02-01
COMPLETED
ADNI: Alzheimer's Disease Neuroimaging InitiativeNCT00106899 · lead sponsor · 2005-07-01
COMPLETED
Valproate in Dementia (VALID)NCT00071721 · lead sponsor · 2003-10-01
COMPLETED
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)NCT06223360 · collaborator · 2024-03-28
ACTIVE_NOT_RECRUITING
A Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early ADNCT03919162 · collaborator · 2021-11-15
TERMINATED
Study of BHV-4157 in Alzheimer's DiseaseNCT03605667 · collaborator · 2018-07-31
COMPLETED
Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's DiseaseNCT02925650 · collaborator · 2017-03-02
COMPLETED
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)NCT02079909 · collaborator · 2014-03-01
COMPLETED
A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s DiseaseNCT00818662 · collaborator · 2008-12-19
COMPLETED
Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's DiseaseNCT00876863 · collaborator · 2008-11-01
COMPLETED
A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's DiseaseNCT00566397 · collaborator · 2007-12-01
COMPLETED
Anti-Oxidant Treatment of Alzheimer's DiseaseNCT00117403 · collaborator · 2006-01-01
COMPLETED
Huperzine A in Alzheimer's DiseaseNCT00083590 · collaborator · 2004-04-01
COMPLETED
VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)NCT00056225 · collaborator · 2003-01-01
COMPLETED
Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease StudyNCT00053599 · collaborator · 2002-12-01
COMPLETED
Memory Impairment Study (Mild Cognitive Impairment Study)NCT00000173 · collaborator · 1999-03-01
COMPLETED
A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)NCT00004845 · collaborator
COMPLETED

Sponsor roles

collaborator14
lead sponsor8
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.